Overall survival according to genetic abnormality in 126 patients treated with autologous stem cell transplantation (ASCT).15
| Abnormality . | N(%) . | Median OS (months) . | Relative Risk (95% CI) . | pvalue . |
|---|---|---|---|---|
| p53 del | 10 (8) | 14.7 | 4.5 (1.5–13.1) | 0.0025 |
| t(4:14) | 15 (12) | 18.3 | 4.8 (1.8–12.7) | 0.0005 |
| t(11:14) | 16 (13) | 37.2 | 1.5 (0.5–4.8) | 0.5231 |
| 13q del | 39 (31) | 34.4 | 2.3 (1.0–5.2) | 0.0498 |
| None | 43 (34) | not reached | 1.0 |
| Abnormality . | N(%) . | Median OS (months) . | Relative Risk (95% CI) . | pvalue . |
|---|---|---|---|---|
| p53 del | 10 (8) | 14.7 | 4.5 (1.5–13.1) | 0.0025 |
| t(4:14) | 15 (12) | 18.3 | 4.8 (1.8–12.7) | 0.0005 |
| t(11:14) | 16 (13) | 37.2 | 1.5 (0.5–4.8) | 0.5231 |
| 13q del | 39 (31) | 34.4 | 2.3 (1.0–5.2) | 0.0498 |
| None | 43 (34) | not reached | 1.0 |